Clinical Trial: Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Castration-resistant Prostate Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
Brief Summary:
This is a multicenter, single-arm, two-stage open-label phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate cancer (CRPC).
Read more